background classic scrap sheep fatal neurodegen disease assoc covers prec press much known gene suspect uptake dissemin body mani aspect prior disease still unknown differ proteam technique use last dead investing differ protein profil affect anim health control investing serum selditofm cms latent variable method principal common analysis partial least squaresdiscrimin target project describe m data result show group throughout incur period clinic end stage model spear two density amyloid identify one peak differ significantly concur ten solid discrimin group nonclin individual differ express time point investing comic contribute new insight under process pathway advance understand comparison valid across laboratory difficult challenge 